Mar 31, 2025 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to VolitionRX Limited fourth quarter and full fiscal year 2024 earnings conference call. (Operator Instructions) This conference call is being recorded today, March 31, 2025.
I would now like to turn the conference over to Louise Batchelor, Group Chief Marketing and Communications Officer. Please go ahead.
Louise Batchelor - VolitionRX Ltd - Group Chief Marketing and Communications Officer
Thank you, and welcome, everyone, to today's earnings conference call for VolitionRX Limited.
Before we begin, I'd like to remind everyone that some of the information discussed on this conference call will include forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on our beliefs as well as the assumptions we have used based upon information currently available to us.
Because these statements reflect our current views concerning future events, these statements involve risks
Q4 2024 VolitionRX Ltd Earnings Call Transcript
Apr 01, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers